Article
Clinical Genetic Features and Neoadjuvant Chemotherapy Response in HER2-Low Breast Cancers: A Retrospective, Multicenter Cohort Study.
Annals of surgical oncology - 1 Sept 2023
Yang Libo, Liu Yuqiong, Han DanDan, Fu Sha, Guo Shuangping, Bao Longlong, Shi Yi, Huang Rongfang, Wan Huan, Li Wencai, Wang Zhe, Zhou Xiaoyan, Chen Gang, Liu Yueping, Ye Feng
Abstract excerpt
BACKGROUND: The objective of this work is to reveal differences in clinical and genetic features, as well as neoadjuvant chemotherapy (NAC) response, between HER2-low and HER2-zero or HER2-positive breast cancers. PATIENTS AND METHODS: A total of 245 female patients with breast cancer were retros...
Topics
- Humans
- Female
- Breast Neoplasms
- Retrospective Studies
- Receptor, ErbB-2
- Neoadjuvant Therapy
- Mutation
- Antineoplastic Combined Chemotherapy Protocols